Table 3.

The percentage distribution of patients with the pseudoprogression and glioblastoma recurrence as the function of calculated cut-offs.

		Pseudoprogression (n = 19)	Recurrence (n = 59)	p
tCho/tNAA	< 1.3	18 (94.7%)	0	< 0.001
≥ 1.3	1 (5.3%)	59 (100.0%)
Median (min; max)		0.74 (0.33–1.77)	2.13 (1.35–9.60)	< 0.001
tCho/tCr	< 0.7	11 (57.9%)	15 (25.4%)	0.013
≥ 0.7	8 (42.1%)	44 (74.6%)
Median (min; max)		0.64 (0.28–1.37)	0.89 (0.44–2.83)	0.013
tNAA/tCr	> 0.7	18 (94.7%)	4 (6.8%)	< 0.001
≤ 0.7	1 (5.3%)	55 (93.2%)
Median (min; max)		0.99 (0.28–1.59)	0.41 (0.11–0.96)	< 0.001
Lac + Lip 1.3/tCr	< 1.6	12 (63.2%)	14 (23.7%)	0.004
≥ 1.6	7 (36.8%)	45 (76.3%)
Median (min; max)		1.13 (0.07–10.65)	2.69 (0.40–15.63)	0.005
Lac + Lip 0.9–1.3/tCr	< 2.0	13 (68.4%)	13 (22.0%)	< 0.001
≥ 2.0	6 (31.6%)	46 (78.0%)
Median (min; max)		1.33 (0.08–12.35)	3.26 (0.54–17.42)	0.004
ADCmean	> 1313	19 (100.0%)	1 (1.7%)	< 0.001
≤ 1313	0	58 (98.3%)
Median (min; max)		1372 (1317–1476)	1155(756–1344)	< 0.001